Biblio

Export 1458 results:
Author Title Type [ Year(Asc)]
Filters: First Letter Of Last Name is K  [Clear All Filters]
2023
S. Ukraintseva, Duan, H., Holmes, R., Bagley, O., Wu, D., Yashkin, A., Kulminski, A., Akushevich, I., Whitson, H., Stallard, E., Yashin, A., and Arbeev, K., Patterns of Aging Changes in Bodyweight May Predict Alzheimer's Disease., J Alzheimers Dis, vol. 97, no. 1, pp. 163-170, 2023.
M. Rafi Khezri, Ghasemnejad-Berenji, M., and Moloodsouri, D., The PI3K/AKT Signaling Pathway and Caspase-3 in Alzheimer's Disease: Which One Is the Beginner?, J Alzheimers Dis, vol. 92, no. 2, pp. 391-393, 2023.
T. Nakamura, Kawarabayashi, T., Ueda, T., Shimomura, S., Hoshino, M., Itoh, K., Ihara, K., Nakaji, S., Takatama, M., Ikeda, Y., and Shoji, M., Plasma ApoE4 Levels Are Lower than ApoE2 and ApoE3 Levels, and Not Associated with Plasma Aβ 40/42 Ratio as a Biomarker of Amyloid-β Amyloidosis in Alzheimer's Disease., J Alzheimers Dis, vol. 93, no. 1, pp. 333-348, 2023.
P. Chatterjee, Doré, V., Pedrini, S., Krishnadas, N., Thota, R., Bourgeat, P., Ikonomovic, M. D., Rainey-Smith, S. R., Burnham, S. C., Fowler, C., Taddei, K., Mulligan, R., Ames, D., Masters, C. L., Fripp, J., Rowe, C. C., Martins, R. N., and Villemagne, V. L., Plasma Glial Fibrillary Acidic Protein Is Associated with 18F-SMBT-1 PET: Two Putative Astrocyte Reactivity Biomarkers for Alzheimer's Disease., J Alzheimers Dis, vol. 92, no. 2, pp. 615-628, 2023.
Y. Jayne Tan, Siow, I., Saffari, S. Ehsan, Ting, S. K. S., Li, Z., Kandiah, N., Tan, L. C. S., Tan, E. King, and Ng, A. S. L., Plasma Soluble ST2 Levels Are Higher in Neurodegenerative Disorders and Associated with Poorer Cognition., J Alzheimers Dis, vol. 92, no. 2, pp. 573-580, 2023.
H. Kikuchi, Takahashi, M., Komatsu, H., and Axelsen, P. H., Post-Translational Chemical Modifications of Amyloid-β Peptides by 4-Hydroxy-2-Nonenal., J Alzheimers Dis, vol. 92, no. 2, pp. 499-511, 2023.
H. Kikuchi, Takahashi, M., Komatsu, H., and Axelsen, P. H., Post-Translational Chemical Modifications of Amyloid-β Peptides by 4-Hydroxy-2-Nonenal., J Alzheimers Dis, vol. 92, no. 2, pp. 499-511, 2023.
S. Marcolini, Rojczyk, P., Seitz-Holland, J., Koerte, I. K., Alosco, M. L., and Bouix, S., Posttraumatic Stress and Traumatic Brain Injury: Cognition, Behavior, and Neuroimaging Markers in Vietnam Veterans., J Alzheimers Dis, vol. 95, no. 4, pp. 1427-1448, 2023.
D. E. Bredesen, Toups, K., Hathaway, A., Gordon, D., Chung, H., Raji, C., Boyd, A., Hill, B. D., Hausman-Cohen, S., Attarha, M., Chwa, W. Jong, Kurakin, A., and Jarrett, M., Precision Medicine Approach to Alzheimer's Disease: Rationale and Implications., J Alzheimers Dis, vol. 96, no. 2, pp. 429-437, 2023.
T. Voss, Kost, J., Mercer, S. Pal, Furtek, C., Randolph, C., Lines, C., Egan, M. F., and Cummings, J. L., Progression from Prodromal Alzheimer's Disease to Mild Alzheimer's Disease Dementia in the Verubecestat APECS Study: Adjudicating Diagnostic Transitions., J Alzheimers Dis, vol. 92, no. 1, pp. 341-348, 2023.
K. Katisko, Krüger, J., Soppela, H., Hartikainen, P., Haapasalo, A., Remes, A. M., and Solje, E., Psychopharmacological Medication Use in Frontotemporal Dementia at the Time of Diagnosis: Comparison with Alzheimer's Disease., J Alzheimers Dis, vol. 95, no. 2, pp. 677-685, 2023.
K. Katisko, Krüger, J., Soppela, H., Hartikainen, P., Haapasalo, A., Remes, A. M., and Solje, E., Psychopharmacological Medication Use in Frontotemporal Dementia at the Time of Diagnosis: Comparison with Alzheimer's Disease., J Alzheimers Dis, vol. 95, no. 2, pp. 677-685, 2023.
C. W. Zhu, Gu, Y., Cosentino, S., Kociolek, A. J., Hernandez, M., and Stern, Y., Racial/Ethnic Disparities in Misidentification of Dementia in Medicare Claims: Results from the Washington Heights-Inwood Columbia Aging Project., J Alzheimers Dis, vol. 96, no. 1, pp. 359-368, 2023.
K. Surya, Manickam, N., Jayachandran, K. Swaminatha, Kandasamy, M., and Anusuyadevi, M., Resveratrol Mediated Regulation of Hippocampal Neuroregenerative Plasticity via SIRT1 Pathway in Synergy with Wnt Signaling: Neurotherapeutic Implications to Mitigate Memory Loss in Alzheimer's Disease., J Alzheimers Dis, vol. 94, no. s1, pp. S125-S140, 2023.
F. C. T. van der Heide, Mokhtar, S., Khanna, A., Said, M., Henry, R. M. A., Kroon, A. A., Dagnelie, P. C., Eussen, S. J. P. M., Berendschot, T. T. J. M., Schouten, J. S. A. G., Schram, M. T., van der Kallen, C. J. H., van Greevenbroek, M. M. J., Wesselius, A., Savelberg, H. H. C. M., Schaper, N. C., Webers, C. A. B., and Stehouwer, C. D. A., Retinal Functional and Structural Neural Indices: Potential Biomarkers for the Monitoring of Cerebral Neurodegeneration: The Maastricht Study., J Alzheimers Dis, vol. 93, no. 4, pp. 1471-1483, 2023.
F. C. T. van der Heide, Mokhtar, S., Khanna, A., Said, M., Henry, R. M. A., Kroon, A. A., Dagnelie, P. C., Eussen, S. J. P. M., Berendschot, T. T. J. M., Schouten, J. S. A. G., Schram, M. T., van der Kallen, C. J. H., van Greevenbroek, M. M. J., Wesselius, A., Savelberg, H. H. C. M., Schaper, N. C., Webers, C. A. B., and Stehouwer, C. D. A., Retinal Functional and Structural Neural Indices: Potential Biomarkers for the Monitoring of Cerebral Neurodegeneration: The Maastricht Study., J Alzheimers Dis, vol. 93, no. 4, pp. 1471-1483, 2023.
M. Pejstrup Agger, Danielsen, E. Rubæk, Carstensen, M. Schultz, N Nguyen, M., Horning, M., Henney, M. Alexander, Jensen, C. Boe Ravn, Baandrup, A. Ohlhues, Kjær, T. Wesenberg, Madsen, K. Hougaard, Miskowiak, K., Petersen, P. Michael, and Høgh, P., Safety, Feasibility, and Potential Clinical Efficacy of 40 Hz Invisible Spectral Flicker versus Placebo in Patients with Mild-to-Moderate Alzheimer's Disease: A Randomized, Placebo-Controlled, Double-Blinded, Pilot Study., J Alzheimers Dis, vol. 92, no. 2, pp. 653-665, 2023.
G. S. Smith, Kuwabara, H., Yan, H., Nassery, N., Yoon, M., Kamath, V., Kraut, M., Gould, N. F., Savonenko, A., Coughlin, J. M., Lodge, M., Pomper, M. G., Nandi, A., Holt, D., Dannals, R. F., and Leoutsakos, J. M., Serotonin Degeneration and Amyloid-β Deposition in Mild Cognitive Impairment: Relationship to Cognitive Deficits., J Alzheimers Dis, vol. 96, no. 1, pp. 215-227, 2023.
G. S. Smith, Kuwabara, H., Yan, H., Nassery, N., Yoon, M., Kamath, V., Kraut, M., Gould, N. F., Savonenko, A., Coughlin, J. M., Lodge, M., Pomper, M. G., Nandi, A., Holt, D., Dannals, R. F., and Leoutsakos, J. M., Serotonin Degeneration and Amyloid-β Deposition in Mild Cognitive Impairment: Relationship to Cognitive Deficits., J Alzheimers Dis, vol. 96, no. 1, pp. 215-227, 2023.
G. S. Smith, Kuwabara, H., Yan, H., Nassery, N., Yoon, M., Kamath, V., Kraut, M., Gould, N. F., Savonenko, A., Coughlin, J. M., Lodge, M., Pomper, M. G., Nandi, A., Holt, D., Dannals, R. F., and Leoutsakos, J. M., Serotonin Degeneration and Amyloid-β Deposition in Mild Cognitive Impairment: Relationship to Cognitive Deficits., J Alzheimers Dis, vol. 96, no. 1, pp. 215-227, 2023.
R. Biswas, Kawas, C., Montine, T. J., Bukhari, S. A., Jiang, L., and Corrada, M. M., Superior Global Cognition in Oldest-Old Is Associated with Resistance to Neurodegenerative Pathologies: Results from The 90+ Study., J Alzheimers Dis, vol. 93, no. 2, pp. 561-575., 2023.
E. Z. Huie, Escudero, A., Saito, N., Harvey, D., Le Nguyen, M. -, Lucot, K. L., LaGrande, J., Mungas, D., DeCarli, C., Lamar, M., Schneider, J. A., Kapasi, A., Rissman, R. A., Teich, A. F., and Dugger, B. N., TDP-43 Pathology in the Setting of Intermediate and High Alzheimer's Disease Neuropathologic Changes: A Preliminary Evaluation Across Ethnoracial Groups., J Alzheimers Dis, vol. 91, no. 4, pp. 1291-1301, 2023.
S. L. Hartley, Fleming, V., Schworer, E. K., Peven, J., Handen, B. L., Krinsky-McHale, S., Hom, C., Lee, L., Tudorascu, D. L., Laymon, C., Minhas, D., Luo, W., Cohen, A., Zaman, S., Ances, B. M., Mapstone, M., Head, E., Lai, F., H Rosas, D., Klunk, W., and Christian, B., Timing of Alzheimer's Disease by Intellectual Disability Level in Down Syndrome., J Alzheimers Dis, vol. 95, no. 1, pp. 213-225, 2023.
S. L. Hartley, Fleming, V., Schworer, E. K., Peven, J., Handen, B. L., Krinsky-McHale, S., Hom, C., Lee, L., Tudorascu, D. L., Laymon, C., Minhas, D., Luo, W., Cohen, A., Zaman, S., Ances, B. M., Mapstone, M., Head, E., Lai, F., H Rosas, D., Klunk, W., and Christian, B., Timing of Alzheimer's Disease by Intellectual Disability Level in Down Syndrome., J Alzheimers Dis, vol. 95, no. 1, pp. 213-225, 2023.
K. Pushpa Tryphena, Anuradha, U., Kumar, R., Rajan, S., Srivastava, S., Singh, S. Bala, and Khatri, D. Kumar, Understanding the Involvement of microRNAs in Mitochondrial Dysfunction and Their Role as Potential Biomarkers and Therapeutic Targets in Parkinson's Disease., J Alzheimers Dis, vol. 94, no. s1, pp. S187-S202, 2023.

Pages